Acuamark Diagnostics
David Gelfand is the inventor of the real-time PCR (or “qPCR”) or "TaqMan" Assay. Previously, Vice President, Discovery Research Division and Director for the Program in Core Research at Roche Molecular Systems, Inc. CSO of WaferGen BioSystems, Inc., and currently, a consultant at the Centre National de Génotypage in France.
This person is not in the org chart
This person is not in any offices
Acuamark Diagnostics
Acuamark Diagnostics (formerly iCareDx) develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable.